Treatment pathways and associated costs of metastatic colorectal cancer in Greece

Table 4 Resource utilization during stable disease (pre progression), at disease progression and beyond third line

	Pre progression period for 1st-2nd-3rd lines (times per month)^a	Terminal careBeyond 3rd line period (times per month)^b	Disease progression/One-off resource use at 3-month period (times)^c
Medical consultations
Medical oncologist consultation	0.73	1.6	3
Radiation oncologist consultation	0.083
Oncology nurse visit	0.66	1.3	3
GP consultation	0.2	1	1
Psychology specialist consultation	0.08
Surgeon consultation	0.08
Hospital visits
Inpatient stay (oncology/general ward)	0.06		2
Emergency department visit	0.083
Day hospital visit	0.66	0.5	3
Home care
Best supportive care physician/nurse visit		2
Home aid (non-medical specialist) visit		2.3
Examinations
Whole-body CT	0.32		1
Brain MRI	0.033
Brain CT-scan	0.016
Chest radiograph	0.13
PET-CT scan	0.033
Bone scan	0.05
Blood test (CBC, CMP)	1		3.71
Procedures
Radiotherapy fraction	0.033
Surgical intervention	0.033

^aFor the pre progression period for 1st-2nd-3rd line, resource use is counted on monthly basis,
^bFor terminal care/beyond the 3rd line period, resource use is counted on monthly basis
^cFor the disease progression phase a 3-month period has been estimated for resource use based on the agreement of the advisory board participants

ISSN: 1478-7547